Physeon GmbH Names Patrick Kullmann Chief Executive Officer

March 12, 2018

Physeon GmbH, a leading developer of medical technology products for venous access, announced that the Company has named Mr. Patrick Kullmann as its new Chief Executive Officer.


Patrick Kullmann is an accomplished and experienced senior leader in the MedTech, Bio Tech and Pharmaceutical industries. He has served in numerous leadership positions at large, multinational companies including Johnson and Johnson (JNJ), Boston Scientific (BSX) and Medtronic (MDT). Patrick is also a highly qualified and accomplished leader in the startup space with a proven track record of success in the medical technology field. Physeon is his seventh start up in his 33 years career. Most recently, Patrick served as the COO and President for Medovex Corp. (MDVX) on the NASDAQ and OTC markets. He has successfully raised funding in private and public markets.


"We're very pleased to have Patrick join the Physeon team at such an exciting time in its evolution. Patrick’s background, experience and accomplishments makes him a perfect leader for the organization,” stated Mr. Alan Wilson, CEO of Novintum Medical Technology GmbH, the parent company of Physeon.


Please reload


Veinplicity Impresses at KIMES 2016

April 4, 2016

Please reload

Please reload

Please reload

© 2016 Novintum Medical Technology   -   Privacy Policy   -   Terms of Use